Immune System / Vaccines News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
4 Sep 2010 at 4:00am
As many children head back to school this fall, are they truly prepared for what lies ahead? With a few simple medical exams; Maine's school-age children will be armed with the tools they need to have a healthier school year...
4 Sep 2010 at 2:00am
A study published in the journal Science shows how our bodies try to minimise potential 'collateral damage' caused by our immune system when fighting infection. The research may also provide new clues to why cigarette smoke is a significant risk factor for developing diseases of the lung such as chronic bronchitis and emphysema...
4 Sep 2010 at 2:00am
In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat inflammation, wounds, asthma, and malignant tumors...
3 Sep 2010 at 8:00am
Congolese Community Leaders Warned U.N. About Security; 240 Rape Victims Now Identified "Congolese community leaders say they begged local U.N. officials and army commanders to protect villagers days before rebels gang-raped scores of people, from a month-old baby boy to a 110-year-old great-great-grandmother," the Associated Press reports...
3 Sep 2010 at 8:00am
The National Institutes of Health has announced that it has awarded the first new grants under the Biomedical Research on the International Space Station (BioMed-ISS) initiative, a collaborative effort between NIH and NASA...
3 Sep 2010 at 7:00am
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), for advanced development of the company's third generation anthrax vaccine candidate...
3 Sep 2010 at 4:00am
Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit (RTA)...
3 Sep 2010 at 2:00am
When it comes to the mechanics of the human immune system, we are all more alike than previously thought, according to a new study by scientists at Fred Hutchinson Cancer Research Center. This finding has significant implications for developing new ways to detect, diagnose and treat cancer and diseases of the immune system, according to Harlan Robins, Ph.D...
3 Sep 2010 at 2:00am
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice...
2 Sep 2010 at 5:00am
Be among the first to hear the latest research from the world's leading allergists presented at the 2010 annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI), Nov. 11-16, in Phoenix...
2 Sep 2010 at 4:00am
Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the first-ever release of National Psoriasis Victor Henschel BioBank DNA samples for use in psoriasis research. The samples will allow scientists to uncover the unknowns about the genetics of psoriatic disease and its causes. James T. Elder, M.D., Ph.D...
2 Sep 2010 at 3:00am
Xcellerex, Inc. announced that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, Texas. Project GreenVax is spearheaded by Texas Plant-Expressed Vaccine Consortium, which consists of G-Con, LLC and The Texas A&M University System. Financial terms were not disclosed...
2 Sep 2010 at 2:00am
A study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock...
2 Sep 2010 at 2:00am
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd...
2 Sep 2010 at 2:00am
HIV-infected children receiving highly active antiretroviral therapy (HAART) may require revaccination to maintain immunity against preventable diseases. There remains no standard or official recommendation on revaccination of children receiving HAART, an effective intervention in reducing morbidity and mortality in HIV-infected children...
